| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000029624 |
| Receipt No. | R000033838 |
| Official scientific title of the study | The study regarding screening tests for HIV complications associated with aging in HIV infected patients. |
| Date of disclosure of the study information | 2017/12/01 |
| Last modified on | 2018/04/27 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The study regarding screening tests for HIV complications associated with aging in HIV infected patients. | |
| Title of the study (Brief title) | HIV aging study | |
| Region |
|
|
| Condition | ||
| Condition | HIV infection | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To find out the possibility of early detection of malignant tumors associated with aging in HIV infected patients through performing FDG-PET/CT examinations and tumor marker test. |
| Basic objectives2 | Others |
| Basic objectives -Others | Epidemiology |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Presence of undiagnosed malignant tumor in HIV positive patients with hemophilia |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Starting from December 2017 to the end of December 2020, we will conduct at least one malignant tumor screening tests, including FDG-PET/CT and blood tumor marker test. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) HIV infected patients with hemophilia who are 35 years old or older or
2) HIV litigation plaintiffs resident in Tokai block and 3) Consent to participant has been obtained in a written form. |
|||
| Key exclusion criteria | 1) If an attending physician decides the patient requires urgent treatment
2)A patient with poor control of diabetes (FBS>150mg/dL) 3) A patient with serious underlying disease, which may lead to liver/kidney dysfunction and/or metabolic disorder 4) A patient with mental illness or psychiatric symptoms determined to confront difficulty when participating in the study 5)A patient with history of hypersensitivity to FDG 6) Other patients, whose attending physician has determined inappropriate to participant |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshiyuki Yokomaku |
| Organization | National Hospital Organization Nagoya Medical Center |
| Division name | Department of AIDS clinic |
| Address | 4-1-1 Sannnomaru, Naka-ku, Nagoya, Aichi, Japan |
| TEL | 052-951-1111 |
| yokomaku@nnh.hosp.go.jp | |
| Public contact | |
| Name of contact person | Yoshiyuki Yokomaku |
| Organization | National Hospital Organization Nagoya Medical Center |
| Division name | Department of AIDS clinic |
| Address | 4-1-1 Sannnomaru, Naka-ku, Nagoya, Aichi, Japan |
| TEL | 052-951-1111 |
| Homepage URL | |
| yokomaku@nnh.hosp.go.jp | |
| Sponsor | |
| Institute | National Hospital Organization Nagoya Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 名古屋医療センター(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033838 |